Cellulose Sulfate (CS) Gel and HIV in Nigeria
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00120770|
Recruitment Status : Terminated (The study was halted in January 2007 due to safety concerns.)
First Posted : July 19, 2005
Last Update Posted : February 28, 2007
|Condition or disease||Intervention/treatment||Phase|
|HIV Infections Gonorrhea Chlamydia Infections||Drug: Cellulose Sulfate Vaginal Gel (Microbicide)||Phase 3|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||2160 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Randomized Controlled Trial of Cellulose Sulfate Gel and HIV in Nigeria|
|Study Start Date :||November 2004|
|Estimated Study Completion Date :||March 2007|
- Incidence of HIV-1 and HIV-2 infection as determined by detection of HIV antibodies from oral mucosal transudate (OMT) specimens.
- Incidence of genital gonorrhea or chlamydia as determined by DNA probe technology from self-administered vaginal swabs.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00120770
|Lagos University, College of Medicine, Center 10151|
|University of Port Harcourt Teaching Hospital, Center 10152|
|Port Harcourt, Nigeria|
|Study Director:||Vera Halpern, MD||FHI 360|